http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0609738-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f736c394e6f078a9fc4f87c318360f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5784d748f1281ae814896cff35f6b52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b77e694da7e28264f8f7d48f286f64 |
| publicationDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0609738-A2 |
| titleOfInvention | pharmaceutically acceptable compound and salts thereof, pharmaceutical formulation, methods for treating or reducing the risk of a human disease or condition, disorders or disease, and multiple sclerosis and for treating or prophylaxis of atherosclerosis, use of a compound or a pharmaceutically acceptable salt thereof, and process for preparing a compound or a pharmaceutically acceptable salt thereof |
| abstract | COMPOUND AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL FORMULATION, METHODS FOR TREATING, OR REDUCING THE RISK OF A HUMAN DISEASE OR DISEASE, AND STERLOSIS OR PROPHETOSIS, FOR MULTIPLEXIS OR MUSCLUS, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PROCESS FOR PREPARING A PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT THEREOF. New 5-substituted 7-amino- [1,3] thiazolo [4,5-d] pyrimidine derivatives of formula (I) are disclosed, wherein R 1, R 2, R 3, R 3 R 4 and R 5 are as defined in the specification, and pharmaceutically acceptable salts thereof, together with processes for their preparation, pharmaceutical compositions comprising them and their use in therapy. The compounds of formula (I) are CX3CR1 receptor antagonists and are thus particularly useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease, cardio- and cerebrovascular atherosclerotic disorders, peripheral artery disease, rheumatoid arthritis, pulmonary disease such as COPD, asthma or pain. |
| priorityDate | 2005-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 487.